Abstract
The dependence of lithium-induced polydipsia (LIP) on central monoamine pathways was investigated using several pharmacological manipulations. Intracisternal administration of 6-hydroxydopamine (6-OHDA) in combination with pargyline or desipramine was used to deplete dopamine (DA), norepinephrine, or both catecholamines. Significant decreases in LIP were seen after treatments that depleted brain DA, whereas depletion of norepinephrine alone did not affect LIP. Site-specific injection of 6-OHDA into the substantia nigra or caudate nucleus, but not the nucleus accumbens or noradrenergic dorsal bundle, also caused a decrease in LIP. Depletion of serotonin by intracisternal administration of 5,7-dihydroxytryptamine also had no effect on LIP. Consistent with these findings, the DA receptor blocker haloperidol attenuated LIP. Thus, LIP appears to be dependent on intact nigrostriatal DA fibers, but not on other monoaminergic systems in the brain. Lithium also increased plasma renin activity (PRA) and angiotensin I and II immunoreactivity in plasma, though the time course of LIP onset did not directly parallel these latter changes in the renin-angiotensin axis. Neither the PRA or angiotensin II immunoreactivity in lithium-treated animals was sufficiently high to account for LIP. In addition, the 6-OHDA lesions of the caudate nucleus or substantia nigra that attenuated LIP did not affect the lithium-induced increases in PRA or in angiotensin I or II concentrations. Thus, LIP probably involves mechanisms other than just being a direct response to lithium-induced increases in PRA or angiotensin II concentration and simply may not be secondary to lithium-induced polyuria. Because of the similar pharmacological characteristics of angiotensin II and lithium-induced drinking, a role for angiotensin receptors in LIP cannot be ruled out.
Similar content being viewed by others
References
Barrett JD, Eggena P, Sambhi M (1977) Extraction and measurement of circulating angiotensin I and II. Clin Chem 23:464–468
Blaine EH, Hosutt J, Rowland N, Stricker EM, Zimmerman MB (1979) Water intake and plasma renin activity of rats after intravenous infusions of rat renin. Physiol Behav 23:605–607
Breese GR, Smith RD, Cooper BR, Grant LD (1973) Alterations in consummatory behavior following intracranial injection of 6-hydroxydopamine. Pharmacol Biochem Behav 1:319–328
Buggy J, Fisher AE (1976) Anteroventral third ventricle site of action for angiotensin-induced thirst. Pharmacol Biochem Behav 4:651–660
Casner P, Goldman HW, Lehr D (1975) Participation of cholinergic circuits in renin-induced drinking. Life Sci 16:573–584
Christensen S (1974) Effects of water deprivation in rats with polydipsia and polyuria due to long-term administration of lithium. Acta Pharmacol Toxicol (Copenh) 35:201–211
Cox M, Singer I (1975) Lithium and H2O metabolism. Am J Med 59:153–157
Dantzer R (1980) Effects of postnatal lead exposure on lithium induced polydipsia and glucoprivic feeding in rats. Neurobehav Toxicol 2:373–377
Fitzsimons JT, Setler PE (1971) Catecholaminergic mechanisms in angiotensin-induced drinking. J Physiol (London) 218:43–44
Fitzsimons JT, Setler PE (1975) The relative importance of central nervous system catecholaminergic and cholinergic mechanisms in drinking in response to angiotensin and other thirst stimuli. J Physiol (London) 250:613–631
Govoni S, Montefusco O, Spano PG, Trabucchi M (1978) Effect of chronic lead treatment on brain dopamine synthesis and serum prolactin release in the rat. Toxicol Lett 2:333–337
Gutman Y, Benzakein F, Livneh P (1971) Polydipsia induced by isoprenaline and by lithium: Relation to kidneys and renin. Eur J Pharmacol 16:380–384
Gutman Y, Tamir N, Benzakein F (1973) Effect of lithium on plasma renin activity. Eur J Pharmacol 24:347–351
Haber E, Koerner T, Page LB, Kliman B, Pernode A (1964) Application of a radioimmunoassay for angiotensin I to physiological measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metabol 29:1349–1355
Hildebrand R, Opitz K (1977) Entry of lithium into various regions of the rat brain following the administration of different lithium preparations. Cell Mol Biol 22:379–382
Hoffman WE, Phillips MI (1976) Regional study of cerebral ventricle sensitive sites to angiotensin II. Brain Res 110:313–330
Jason KM, Kellogg CK (1981) Neonatal lead exposure: Effects on development of behavior and striatal dopamine neurons. Pharmacol Biochem Behav 15:641–649
Johnson AK, Mann JFE, Rascher W, Johnson JK, Ganten D (1981) Plasma angiotensin II concentrations and experimentally induced thirst. Am J Physiol 240:229–234
Kikta DC, Threatte RM, Barney CC, Fregly MJ, Greenleaf JE (1981) Peripheral conversion of l-5-hydroxytryptophan to serotonin induces drinking in rats. Pharmacol Biochem Behav 14:889–893
Kilts CD, Breese GR, Mailman RB (1981) Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compound by means of reversed phase high-performance liquid chromatography with electrochemical detection. J Chromatogr 225:347–357
König JFR, Klippel RA (1963) The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams Wilkins, Baltimore
Mailman RB, Krigman MR, Mueller RA, Mushak P, Breese GR (1978) Lead exposure during infancy permanently increases lithium-induced polydipsia. Science 201:637–639
Mailman RB, Breese GR, Krigman MR, Mushak P, Mueller RA (1979) Lead enhancement of lithium-induced polydipsia. Science 205:726
Memo M, Lucchi L, Spano PF, Trabucchi M (1981) Dose-dependent and reversible effects of lead on rat dopaminergic system. Life Sci 28:795–799
Meyer DK, Phillips MI, Eiden L (1982) Studies on the presence of angiotensin II in rat brain. J Neurochem 38:816–820
Mukherjee BP, Bailey PT, Pradhan SN (1976) Temporal and regional differences in brain concentrations of lithium in rats. Psychopharmacology 48:119–121
Nelson SC, Herman MM, Bensch KG, Barchas JD (1980) Localization and quantitation of lithium in rat tissue following intraperitoneal injections of lithium chloride. II. Brain. J Pharmacol Exp Ther 212:11–15
Page LB, Haber E, Kimura AY, Pernode A (1969) Studies with the radioimmunoassay for angiotensin II and its application to measurement of renin activity. J Clin Endocrinol Metab 29:200–206
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum, New York
Perumal TA, Rao JP (1974) Effect of pharmacological blockade on lithium-induced water drinking. Br J Pharmacol 51:107–108
Schou M (1957) Biology and pharmacology of the lithium ion. Pharmacol Rev 9:17–58
Schreiber V, Rohácová J (1971) Diuretic action of lithium carbonate on rats. Acta Endocrinol 68:686–695
Simonnet G, Giorguieff-Chesselet MF, Carayon A, Bioulac B, Cesselin F, Glowinski J, Vincent JD (1981) Angiotensin II et système nigronéostriatal. J Physiol (Paris) 77:71–79
Smith DF (1974) The effect of NH4Cl on polyuria and polydipsia during pro-longed lithium administration in the rat. Acta Pharmacol Toxicol (Copenh) 34:121–129
Spirtes M (1976) Lithium levels in monkey and human brain after chronic therapeutic oral dosage. Pharmacol Biochem Behav 5:143–147
Stricker EM (1977) The renin-angiotensin system and thirst: A reevaluation. II. Drinking elicited in rats by caval ligation or isoproterenol. J Comp Physiol Psychol 91:1220–1231
Stricker EM (1978) The renin-angiotensin system and thirst: Some unanswered questions. Fed Proc 37:2704–2710
Stricker EM, Bradshaw WG (1974) The renin-angiotensin system and thirst: A reevaluation. Science 194:1169–1170
Sumners C, Woodruff GN, Poat JA (1981) Effects of specific dopamine lesions and dopamine receptor sensitivity on angiotensin II- and carbachol-induced thirst in rats. Psychopharmacology 73:180–183
Threatte RM, Fregly MJ, Connor TM, Kikta DC (1981) l-5-Hydroxytryptophan-induced drinking in rats: Possible mechanisms for induction. Pharmacol Biochem Behav 14:385–391
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mailman, R.B. Lithium-induced polydipsia: Dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system. Psychopharmacology 80, 143–149 (1983). https://doi.org/10.1007/BF00427958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427958